Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, today announced the publication of a prospective real-world study demonstrating that its AI imaging ...

FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...

Dr. Barnard explains how his research suggests that processed meat may negatively affect not only your heart health, but also ...

Columnist Samuel Kirton shares his emergency "go bag" checklist of things he brought when he received a bilateral lung ...

VANCOUVER, BC, Dec. 2, 2025 /CNW/ - BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and ...

New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

Shares of Arcturus Therapeutics ARCT have plunged 59.4% in the past three months. The massive stock price drop was primarily ...

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

Propanc Biopharma (PPCB) submitted a request for a foreign filing license from Spain for two provisional patents detailing new methods to treat ...

For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...